medicalxpress - On any given night, 60,000 people in Canada will go to sleep homeless. Research estimates that more than half of them have had a brain injury at one point in their lives, most of them being injured before becoming homeless. An estimated 22.5% live with mo…
#healthcare #publichealth #governmentpolicy
Saturday, February 21, 2026, 6:23 pm / permalink 19543 / 4 stories in 23 days
medicalxpress - Parenting can be hard and can feel especially overwhelming when children have strong emotions, such as anger, frustration or excitement, that they are not always able to regulate on their own.
Saturday, February 21, 2026, 2:22 pm / permalink 19534 / 4 stories in 23 days
Paige Twenter / beckershospitalreview - As U.S. healthcare increasingly adopts team-based care, medical schools are working to prepare students for future care delivery models, according to a Feb. 18 article from the Association of American Medical Colleges. Team-based care, or a coordinated ba…
#healthcare #publichealth #fda #digitalhealth #medicaldevices
Saturday, February 21, 2026, 12:22 pm / permalink 19529 / 3 stories in 23 days
fiercehealthcare - Optum is rolling out a new AI tool that aims to address some of the key barriers to value-based care, from data fragmentation to administrative burden.
Saturday, February 21, 2026, 10:22 am / permalink 19522 / 21 stories in 23 days
Mariah Taylor / beckershospitalreview - Nashville, Tenn.-based Vanderbilt Health researchers have developed a promising novel vaccine to treat Clostridioides difficile infections. Previous vaccine strategies targeted the bacterium’s primary toxins, according to a Feb. 18 system news release. Th…
#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #vaccinesafety
Saturday, February 21, 2026, 7:21 am / permalink 19520 / 2 stories in 23 days
Kyle LaHucik / endpoints - Novartis will pay $100 million upfront to tap into a macrocyclic peptide platform from Unnatural Products, a deal that could lead to new cardiovascular disease medicines. The move allows the Swiss pharma giant to delve ...
#healthcare #pharmaceuticals #biotech #mergersandacquisitions #drugdevelopment
Saturday, February 21, 2026, 6:22 am / permalink 19517 / 2 stories in 23 days
Frank Vinluan / medcitynews - The FDA asked for more data to determine whether Disc Medicine’s bitopertin is benefiting patients with erythropoietic protoporphyria, a rare blood disorder. Analysts say it’s a surprising delay considering bitopertin is one of the first drugs in a new FD…
#healthcare #pharmaceuticals #biotech #drugdevelopment #fda
Saturday, February 21, 2026, 6:22 am / permalink 19516 / 5 stories in 23 days
Kellen K. Petersen / nature - Nature Medicine, Published online: 19 February 2026; doi:10.1038/s41591-026-04206-yPlasma p-tau217 tests used to develop clocks that predict when cognitively unimpaired individuals would develop symptoms of Alzheimerʼs disease.
#healthcare #publichealth #biotech #drugdevelopment #fda #medicaldevices
Saturday, February 21, 2026, 2:22 am / permalink 19513 / 13 stories in 23 days
Ngai Yeung / endpoints - In a bid to build out its global presence, Hims is buying Australian digital health company Eucalyptus in a deal worth $240 million upfront. The deal announced Thursday morning would allow Hims to launch in ...
#healthcare #mergersandacquisitions #corporatetakeover #digitalhealth
Saturday, February 21, 2026, 1:23 am / permalink 19510 / 5 stories in 23 days
livescience - NASA is targeting March 6 as the earliest possible launch date for the Artemis II mission to the moon following a successful 'wet dress rehearsal' on Thursday.
Saturday, February 21, 2026, 1:22 am / permalink 19509 / 5 stories in 23 days
Paige Twenter / beckershospitalreview - Six weeks into 2026, the CDC has confirmed 910 measles cases. If the pace of transmission continues, this year could far outpace the 2,280 cases detected across the U.S. in 2025, as 2026’s total is already 40% of 2025’s. The hardest-hit state is South Car…
#healthcare #publichealth #cdc #vaccinesafety
Saturday, February 21, 2026, 1:22 am / permalink 19508 / 11 stories in 23 days
Sydney Halleman / healthcaredive - Nonprofit Prime Foundation, an affiliate of for-profit hospital operator Prime Healthcare, now owns 21 hospitals across eight states.
#healthcare #mergersandacquisitions #corporatetakeover
Saturday, February 21, 2026, 12:23 am / permalink 19504 / 3 stories in 23 days
Dani James / healthcaredive - The drugstore retailer said it was simplifying its organization to speed up decision-making in a move impacting at least 600 workers.
#healthcare #pharmaceuticals #mergersandacquisitions
Saturday, February 21, 2026, 12:23 am / permalink 19503 / 2 stories in 23 days
discovermagazine - A previously unknown virus may be the key to assessing the risk of colorectal cancer and improving diagnosis.
#healthcare #publichealth #biotech #oncology
Saturday, February 21, 2026, 12:23 am / permalink 19502 / 13 stories in 23 days
abcnews - A ransomware attack has forced the University of Mississippi Medical Center to close clinics and cancel elective procedures for a second day
#healthcare #publichealth #digitalhealth
Saturday, February 21, 2026, 12:23 am / permalink 19501 / 4 stories in 23 days
Frank Vinluan / medcitynews - Despite missing statistical significance, Grail said the observation of trending improvement suggests potential for better results with more time, so the company is extending follow up by up to a year. More detailed trial results will be submitted for pre…
#healthcare #publichealth #biotech #medicaldevices #oncology
Saturday, February 21, 2026, 12:23 am / permalink 19500 / 9 stories in 23 days
HIMSS 2026 pushes real‑time data, cloud and interoperability playbook 14 stories in 16.5 hours
Neoadjuvant GOLP improves event‑free survival in high‑risk intrahepatic cholangiocarcinoma 3 stories in 17.5 hours
Vitamin D trial shows reduced long‑COVID risk but no severity benefit 2 stories in 19.5 hours
Atezolizumab added to chemoradiation fails to improve limited‑stage SCLC survival 4 stories in 20.5 hours
FDA approves leucovorin for rare folate disorder despite autism hype 4 stories in 32.5 hours
HORMAD1 emerges as a potential target in triple‑negative breast cancer 4 stories in 45.5 hours
Alfasigma pays $300M to GSK for linerixibat rights, expanding liver-disease portfolio 2 stories in 48.5 hours
Roche’s hoped‑for breast cancer pill fails crucial first‑line trial 5 stories in 49.5 hours
Novo Nordisk and Hims bury the hatchet and carve a deal 3 stories in 54.5 hours
AI improves UK breast-screening detection by about 10% 5 stories in 54.5 hours
NorthFeed Inc.
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.
Bluesky: